[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200100175T2 - Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. - Google Patents

Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.

Info

Publication number
TR200100175T2
TR200100175T2 TR2001/00175T TR200100175T TR200100175T2 TR 200100175 T2 TR200100175 T2 TR 200100175T2 TR 2001/00175 T TR2001/00175 T TR 2001/00175T TR 200100175 T TR200100175 T TR 200100175T TR 200100175 T2 TR200100175 T2 TR 200100175T2
Authority
TR
Turkey
Prior art keywords
autoimmune diseases
immunotherapy
new peptides
peptides
treatment
Prior art date
Application number
TR2001/00175T
Other languages
English (en)
Inventor
Franciscus Maria Verheijden Gijbertus
Maria Helena Boots Anna
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200100175T2 publication Critical patent/TR200100175T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bulus, otoimmün hastaliklarin önlenmesi için peptitle meydana getirilen bir tolerans tedavisinde yeni peptitlerin kullanimina ve özel olarak bunlarin, eklem kikirdaginin kronik yikiminin tedavisinde kullanilmasina iliskindir. Bulus ayrica bahsedilen peptitleri içeren farmasötik bilesimleri ve bir test numunesinde otoreaktif T hücrelerinin saptanmasi için bir test yöntemini de kapsar.
TR2001/00175T 1998-07-23 1999-07-16 Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. TR200100175T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202470 1998-07-23

Publications (1)

Publication Number Publication Date
TR200100175T2 true TR200100175T2 (tr) 2001-09-21

Family

ID=8233961

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00175T TR200100175T2 (tr) 1998-07-23 1999-07-16 Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.

Country Status (21)

Country Link
US (1) US6964766B1 (tr)
EP (1) EP1100823A2 (tr)
JP (1) JP2002521388A (tr)
KR (1) KR20010071020A (tr)
CN (1) CN1310724A (tr)
AU (1) AU758310B2 (tr)
BR (1) BR9912378A (tr)
CA (1) CA2334947A1 (tr)
CO (1) CO5090903A1 (tr)
CZ (1) CZ2001286A3 (tr)
HU (1) HUP0103384A3 (tr)
ID (1) ID27998A (tr)
IL (1) IL140825A0 (tr)
NO (1) NO20010355L (tr)
NZ (1) NZ509417A (tr)
PE (1) PE20000931A1 (tr)
PL (1) PL345958A1 (tr)
RU (1) RU2233290C2 (tr)
SK (1) SK1042001A3 (tr)
TR (1) TR200100175T2 (tr)
WO (1) WO2000005254A2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
BR0211468A (pt) 2001-07-24 2004-11-23 Univ Yale Métodos de tratar e de prevenir uma doença inflamátoria em um mamìfero e de identificar um composto útil para tratar uma doença inflamatória em um mamìfero, composto, e kits para tratar e para prevenir uma doença inflamatória em um mamìfero
CN1169829C (zh) * 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
RU2667423C1 (ru) * 2017-06-28 2018-09-19 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ПраймБиоМед" Мышиная гибридома ykl-39, клон 1b2 g4 - продуцент моноклонального антитела, обладающего специфичностью к цитоплазматическому антигену ykl-39 человека

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
TW575583B (en) * 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
EP0805206A3 (en) 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
AU6693996A (en) 1996-08-09 1998-03-06 Human Genome Sciences, Inc. Human chitinase alpha and chitinase alpha-2

Also Published As

Publication number Publication date
BR9912378A (pt) 2001-04-17
JP2002521388A (ja) 2002-07-16
CZ2001286A3 (en) 2001-08-15
HUP0103384A3 (en) 2004-06-28
NO20010355L (no) 2001-03-20
AU5411299A (en) 2000-02-14
HUP0103384A2 (hu) 2001-12-28
CA2334947A1 (en) 2000-02-03
IL140825A0 (en) 2002-02-10
RU2233290C2 (ru) 2004-07-27
WO2000005254A3 (en) 2000-06-15
EP1100823A2 (en) 2001-05-23
WO2000005254A2 (en) 2000-02-03
NZ509417A (en) 2003-03-28
US6964766B1 (en) 2005-11-15
NO20010355D0 (no) 2001-01-22
PE20000931A1 (es) 2000-09-16
KR20010071020A (ko) 2001-07-28
CN1310724A (zh) 2001-08-29
SK1042001A3 (en) 2001-09-11
CO5090903A1 (es) 2001-10-30
ID27998A (id) 2001-05-03
PL345958A1 (en) 2002-01-14
AU758310B2 (en) 2003-03-20
RU2001105086A (ru) 2004-01-20

Similar Documents

Publication Publication Date Title
TR199901971T2 (tr) Bir reseptöre baglanan peptidler ve bilesikler.
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE60032486D1 (de) Prion protein peptide und deren verwendung
TR199802082T2 (tr) Otoantigen ve otoimün hastaliklarin imünoterapisinde kullanilmak için otoantigen yapisal olarak iliskili proteinler.
BR0011132A (pt) Método e "kit" para amostragem e armazenagem de amostras biológicas
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
BR9506377A (pt) Peptídeo compreendendo uma subsequéncia de gp-39 hc proteina gp-39 hc ou peptideos composição farmacéutica uso da proteina gp-39 hc ou um ou mais dos peptídeos composição de diagnostico e processo de diagnóstico e kit de teste para a detecção de céçiças t auto-reativas ativadas
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
NO990823L (no) Homocysteindesulfurase fra protozoen Trichomonas Vaginalis
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
DE69935414D1 (en) Humanes btrcp protein
DK0833842T3 (da) Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme
ATE390440T1 (de) Neuroaktive peptide
BR9811250A (pt) Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii
SE0003099D0 (sv) Adhesive protein and uses therefore
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.